Bone Biologics Corp (BBLG)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $1.10M
Last updated: Nov 17, 2026 at 4:10 PM ET
Bone Biologics Corp (BBLG) Statistics
Bone Biologics (BBLG) has a market cap of $1.10M. Its share count is up 108.20% from a year earlier. It holds $6.09M more cash than debt, 552.56% of its market cap.
Total Valuation
| Market Cap | $1.10M |
|---|---|
| Latest price (Nov 17, 2026) | $0.29 |
Key Dates
The next earnings report is expected on Mar 1, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 1, 2027 (expected) |
|---|---|
| Last Earnings Date | Oct 26, 2026 |
| Fiscal Year End | December |
Price Statistics
The stock is down 81.75% over 52 weeks and trades 32.56% below its 50-day average.
| Beta (1Y) | 1.06 |
|---|---|
| 52-Week Change | -81.75% |
| 1-Month Change | -28.87% |
| 3-Month Change | -54.39% |
| 6-Month Change | -76.83% |
| 5-Year Change | -99.99% |
| 10-Year Change | -99.99% |
| Total Return (1Y) | -81.75% |
| Total Return (3Y CAGR) | -78.47% |
| Total Return (5Y CAGR) | -85.80% |
| Max Drawdown (1Y) | -86.16% |
| Max Drawdown (3Y) | -99.19% |
| Sharpe Ratio (1Y) | -2.40 |
| Correlation with SPY (1Y) | 0.20 |
| 50-Day Average | $0.43 |
| 200-Day Average | $0.98 |
| 52-Week Range | $0.27 to $2.39 |
| RSI (14 Days) | 32.1 |
| Average Volume (20 Days) | 458.64K |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 13.38x current liabilities, and total debt is 0.00x shareholder equity.
| Current Ratio | 13.38x |
|---|---|
| Quick Ratio | 13.38x |
| Debt / Equity | 0.00x |
Returns and Efficiency
Return on equity is -47.75% and return on assets is -44.18% over the last 12 months.
| Return on Equity (ROE) | -47.75% |
|---|---|
| Return on Assets (ROA) | -44.18% |
| ROA (5Y Average) | -88.23% |
| ROIC (5Y Average) | -92.40% |
Scores
BBLG has a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Piotroski F-Score | 3 of 9 |
|---|---|
| Piotroski Strength | Average |
Income Statement
Revenue was $0 over the last 12 months.
| Revenue | $0 |
|---|---|
| Operating Income | -$3.01M |
| Pretax Income | -$2.84M |
| Net Income | -$2.84M |
| Reported EPS (TTM) | -$1.66 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 92.53% of the $6.43M in total assets.
| Cash and Equivalents | $6.09M |
|---|---|
| Total Debt | $0 |
| Net Cash | $6.09M |
| Net Cash Per Share | $1.63 |
| Working Capital | $5.95M |
| Shareholder Equity | $5.95M |
| Book Value Per Share | $1.59 |
| Total Assets | $6.43M |
| Total Liabilities | $480.77K |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $5 of capital spending, operating cash flow left -$2.57M of free cash flow.
| Operating Cash Flow | -$2.57M |
|---|---|
| Capital Expenditures | $5 |
| Free Cash Flow | -$2.57M |
| FCF Per Share | -$0.76 |
Trailing 12 months through Sep 30, 2026.
Growth
| Book Value Per Share Growth (2Y CAGR) | -65.29% |
|---|---|
| Tangible Book Per Share Growth (2Y CAGR) | -65.29% |
Stock Splits
The last split was a 1-for-6 reverse split on Jun 10, 2025.
| Last Split Date | Jun 10, 2025 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:6 |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About BBLG
What is BBLG's market cap?
Bone Biologics has a market cap of $1.10M.
How many shares of BBLG are outstanding?
Bone Biologics has 3.74M shares outstanding. The count is up 108.20% from a year earlier.
Does BBLG pay a dividend?
No. Bone Biologics does not pay a dividend.
How much debt does BBLG have?
Bone Biologics has $0 of total debt and $6.09M of cash and equivalents, a net cash position of $6.09M.
BBLG pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors